(9ci)-4-氯-1-甲基-1H-苯并咪唑 | 75438-01-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 中文名称: (9ci)-4-氯-1-甲基-1H-苯并咪唑
• 英文名称: 4-chloro-1-methyl-1H-benzoimidazole
• 英文别名: 4-chloro-1-methyl-1H-benzo[d]imidazole；4-chloro-1-methylbenzimidazole
• CAS: 75438-01-6
• 化学式: C₈H₇ClN₂
• 分子量: 166.61
• InChiKey: NJLCPTCZOTWGJP-UHFFFAOYSA-N

物化性质

• 熔点：
  78 °C
• 沸点：
  294.4±32.0 °C(Predicted)
• 密度：
  1.30±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (9ci)-4-氯-1-甲基-1H-苯并咪唑 、 邻甲酚 、 potassium carbonate 以76%的产率得到
  参考文献：
  名称：

  KULKARNI M. V.; PATIL V. D., ARCH. PHARM., 1981, 314, NO 5, 440-447

  摘要：

  DOI：
• 作为产物：
  描述：

  (9ci)-4-氯-1H-苯并咪唑 、 碘甲烷 生成 (9ci)-4-氯-1-甲基-1H-苯并咪唑
  参考文献：
  名称：

  REDDY V. M.; REDDY K. K., INDIAN J. CHEM., 1979, B 17, NO 5, 441-444

  摘要：

  DOI：

文献信息

• NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY
  申请人：ASAHI KASEI KABUSHIKI KAISHA

  公开号：EP3467930A1

  公开（公告）日：2019-04-10

  The purpose of the present invention is to provide a nonaqueous electrolyte that contains acetonitrile having an excellent balance between viscosity and the dielectric constant and a fluorine-containing inorganic lithium salt, wherein the generation of complex cations comprising a transition metal and acetonitrile is suppressed, excellent load characteristics are exhibited, and increases in internal resistance upon repeated charge/discharge cycles are suppressed; a further purpose of the present invention is to provide a nonaqueous secondary battery. The present invention relates to a nonaqueous electrolyte which contains: a nonaqueous solvent comprising acetonitrile; a fluorine-containing inorganic lithium salt; and a specific nitrogenous cyclic compound typified by benzotriazole.

  本发明的目的是提供一种非水电解液，该电解液含有在粘度和介电常数之间具有极佳平衡的乙腈和含氟无机锂盐，其中包含过渡金属和乙腈的复合阳离子的生成受到抑制，显示出极佳的负载特性，并且在重复充放电循环中内阻的增加受到抑制；本发明的另一个目的是提供一种非水二次电池。本发明涉及一种非水电解液，其中包含：由乙腈组成的非水溶剂；含氟无机锂盐；以及以苯并三唑为典型代表的特定含氮环状化合物。
• Nonaqueous electrolyte and nonaqueous secondary battery
  申请人：Asahi Kasei Kabushiki Kaisha

  公开号：US10756394B2

  公开（公告）日：2020-08-25

  The purpose of the present invention is to provide a nonaqueous electrolyte that contains acetonitrile having an excellent balance between viscosity and the dielectric constant and a fluorine-containing inorganic lithium salt, wherein the generation of complex cations comprising a transition metal and acetonitrile is suppressed, excellent load characteristics are exhibited, and increases in internal resistance upon repeated charge/discharge cycles are suppressed; a further purpose of the present invention is to provide a nonaqueous secondary battery. The present invention relates to a nonaqueous electrolyte which contains: a nonaqueous solvent comprising acetonitrile; a fluorine-containing inorganic lithium salt; and a specific nitrogenous cyclic compound typified by benzotriazole.

  本发明的目的是提供一种非水电解液，该电解液含有在粘度和介电常数之间具有极佳平衡的乙腈和含氟无机锂盐，其中包含过渡金属和乙腈的复合阳离子的生成受到抑制，显示出极佳的负载特性，并且在重复充放电循环中内阻的增加受到抑制；本发明的另一个目的是提供一种非水二次电池。本发明涉及一种非水电解液，其中包含：由乙腈组成的非水溶剂；含氟无机锂盐；以及以苯并三唑为典型代表的特定含氮环状化合物。
• Nonaqueous Electrolyte and Nonaqueous Secondary Battery
  申请人：Asahi Kasei Kabushiki Kaisha

  公开号：US20180062213A1

  公开（公告）日：2018-03-01

  The purpose of the present invention is to provide a nonaqueous electrolyte that contains acetonitrile having an excellent balance between viscosity and the dielectric constant and a fluorine-containing inorganic lithium salt, wherein the generation of complex cations comprising a transition metal and acetonitrile is suppressed, excellent load characteristics are exhibited, and increases in internal resistance upon repeated charge/discharge cycles are suppressed; a further purpose of the present invention is to provide a nonaqueous secondary battery. The present invention relates to a nonaqueous electrolyte which contains: a nonaqueous solvent comprising acetonitrile; a fluorine-containing inorganic lithium salt; and a specific nitrogenous cyclic compound typified by benzotriazole.
• [EN] BENZAZOLE DERIVATIVES FOR THE TREATMENT OF INFLAMMATIONS<br/>[FR] DÉRIVÉS DE BENZAZOLE POUR LE TRAITEMENT D'INFLAMMATIONS
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2008084218A1

  公开（公告）日：2008-07-17

  [EN] There is provided compounds of formula (I), wherein the dotted lines, X and R¹ to R¹⁵ have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
  [FR] L'invention porte sur des composés de formule (I), dans laquelle les traits pointillés, X et R¹ à R¹⁵ ont les significations données dans la description, et sur les sels pharmaceutiquement acceptables de ces composés. Ces composés et leurs sels sont utiles dans le traitement de maladies dans lesquelles une inhibition de l'activité d'un membre de la famille MAPEG est souhaitée et/ou requise, et en particulier dans le traitement de l'inflammation.